Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Clinical trial NCT03358472 · COMPLETED
Trial details
- NCT number
- NCT03358472
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2018-07-19
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.